<?xml version="1.0" encoding="UTF-8"?>
<p>The study was approved by the German regulatory authorities (Paul Ehrlich Institute, Vorlage‐Nr.: 1552101) and the local institutional review board (Landesamt für Gesundheit und Soziales, 12/0045). Written informed consent was collected from all patients, and the study was registered under ClinicalTrials.gov with the identifier NCT01525667 and the European Clinical Trials Database Eudra‐CT (2011‐003934‐16). All study procedures have been in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.</p>
